Site Members can sign up for company wide alerts
Lawsuit Overview
March 06, 2026 - An investor in shares of Nektar Therapeutics (NASDAQ: NKTR) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by Nektar Therapeutics in connection with certain allegedly false and misleading statements made between February 26, 2025 and December 15, 2025. San Francisco, CA based Nekt...
You must register (for free) or login to view the entire case.
